MannKind grants Tolero Pharmaceuticals rights to its BTK program for cancer and inflammation
Drug Discovery Tools
- Drug Discovery Tools
- R+D and Marketing-Licensing
- Intra-Biotech Deal
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.